Effects of medicinal herb salvia miltiorrhiza on osteoblastic cells in vitro

Journal of Orthopaedic Research

Volumn 29, Issue 7, 2011, Pages 1059-1063

  Chin, Alice ^a   Yang, Yanqi ^a   Chai, Lei ^a   Wong, Ricky W K ^a   Rabie, Abou Bakr M ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

osteoblasts; Salvia Miltiorrhiza

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; MESSENGER RNA; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; SALVIA MILTIORRHIZA EXTRACT;

ARTICLE; BONE REMODELING; CELL STRAIN 3T3; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; GENE EXPRESSION REGULATION; IN VITRO STUDY; OSTEOBLAST; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

3T3 CELLS; ALKALINE PHOSPHATASE; ANIMALS; BONE REMODELING; GENE EXPRESSION; MEDICINE, CHINESE TRADITIONAL; MICE; OSTEOBLASTS; OSTEOCALCIN; OSTEOGENESIS; OSTEOPROTEGERIN; PLANT PREPARATIONS; RANK LIGAND; SALVIA MILTIORRHIZA;

EID: 79955895930     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.21376     Document Type: Article

References (27)

1. Wong RWK, Rabie ABM,. 2006. Effect of naringin on bone cells. J Orthop Res 24: 2045-2050. (Pubitemid 44717966)
2. Wong RWK, Rabie ABM,. 2011. Effect of psoralen on bone formation. J Orthop Res 29: 158-164.
3. Takeshita S, Pu LQ, Stein LA, et al. 1994. Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia. Circulation 90: 1128.
4. Harada K, Friedman M, Lopez JJ, et al. 1996. Vascular endothelial growth factor administration in chronic myocardial ischemia. Am J Physiol 270: 1791.
5. Baffour R, Berman J, Garb JL, et al. 2004. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: Dose response effect of basic fibroblast growth factor. J Vasc Surg 16: 181.
6. Simons M, Bonow RO, Chronos NA, et al. 2000. Clinical trials in coronary angiogenesis, issues, problems, consensus: An expert panel summary. Circulation 102: 73.
7. Zhu YP, Dan S,. 1998. Chinese materia medica, chemistry, pharmacology and applications, 1st ed. Netherlands: Harwood Academic Publishers; 459-463 p.
8. Wong RWK, Rabie ABM,. 2008. Effect of Salvia miltiorrhiza extract on bone formation. J Biomed Mater Res 85A: 506-512. (Pubitemid 351535333)
9. Hu MZ,. 1993. Effect of radix Salvia miltiorrhiza on the mitotic activity of osteoblast-like cells isolated from chicken embryo calvariae cultured in vitro. Zhonghua Wai Ke Za Shi 3: 251-253.
10. Simons M, Bonow RO, Chronos NA, et al. 2000. Clinical trials in coronary angiogenesis issues, problems, consensus: An expert panel summary. Circulation 102: E73-E86.
11. Schmid J, Wallkamm B, Hammerle CH, et al. 1997. The significance of angiogenesis in guided bone regeneration. A case report of a rabbit experiment. Clin Oral Implant Res 8: 244-248. (Pubitemid 127688460)
12. Lay IS, Chiu JH, Shiao MS, et al. 2003. Crude extract of Salvia miltiorrhiza and salvianolic acid B enhance in vitro angeiogenesis in murine SVR endothelial cell line. Planta Med 69: 26-32.
13. Li G, Gao Y, Li S, et al. 2009. Study on toxicity of danshensu in beagle dogs after 3-month continuous intravenous infusion. Toxicol Mech Methods 19: 441-446.
14. Gao Y, Liu Z, Li G, et al. 2009. Acute and subchronic toxicity of danshensu in mice and rats. Toxicol Mech Methods 19: 363-368.
15. Suda T, Udagawa N, Nakamura I, et al. 1995. Modulation of osteoclast differentiation by local factors. Bone 17: 87S-91S.
16. Akatsu T, Murakami T, Nishikawa M, et al. 1998. Osteoclastogenesis inhibitory factor suppresses osteoclast survival by interfering in the interaction of stromal cells with osteoclast. Biochem Biophys ResCommun 250: 229-234. (Pubitemid 28463860)
17. Yasuda H, Shima N, Nakagawa N, et al. 1999. A novel molecular mechanism modulating osteoclast differentiation and function. Bone 25: 109-113. (Pubitemid 29322072)
18. Kim HK, Woo ER, Lee HW, et al. 2008. The correlation of Salvia miltiorrhiza extract-induced regulation of osteoclastogenesis with the amount of components tanshinone I, tanshinone IIA, cryptotanshinone, and dihydrotanshinone. Immunopharmacol Immunotoxicol 30: 347-364.
19. Kim HH, Kim JH, Kwak HB, et al. 2004. Inhibition of osteoclast differentiation and bone resorption by tanshinone IIA isolated from Salvia miltiorrhiza Bunge. Biochem Pharmacol 67: 1647-1656. (Pubitemid 38479843)
20. Lee SY, Choi DY, Woo ER,. 2005. Inhibition of osteoclast differentiation by Tanshinones from the root of Salvia miltiorrhiza Bunge. Arch Pharm Res 28: 909-913.
21. Franceschi RT, Iyer BS,. 1992. Relationship between collagen synthesis and expression of the osteoblast phenotype in MC3T3-E1 cells. J Bone Miner Res 7: 235-246.
22. ASubin JE, Liu F, Malaval L, Gupta AK,. 1995. Osteoblast and chondroblast differentiation. Bone 17: 77S-83S.
23. Arnett TR, Henderson B,. 1998. Methods in bone biology, 1st ed. London: Chapman and Hall; 10-12 p.
24. Bilezikian JP, Raisz LG, Rodan GA,. 1996. Principles of bone biology. San Diego: Academic Press.
25. Ding Y, Soma S, Takano Yamamoto T, et al. 1995. Effects of salvia miltiorrhiza bunge (SMB) on MC3T3-E1 cells. J Osaka Univ Dent Sch 35: 21-27.
26. Cui L, Zhou LY, Liu YY, et al. 1994. Preventing cancellous bone loss in steroid-treated rats and stimulating bone formation by water extract of Salvia Miltiorrhiza and Danshensu. Chin Pharmacol Bull 20: 286-291.
27. Liu YR, Qu SX, Maitz MF, et al. 2007. The effect of the major components of Salvia Miltiorrhiza bunge on bone marrow cells. J Ethnopharmacol 111: 573-583. (Pubitemid 46617102)